Physician profile
James Farrell
NPI 1962713677
$6,762.44
in general payments reported to CMS, 2019-2025
36 companies · $945 in 2025
The $945 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $158 · 2021: $3,543 · 2022: $672 · 2023: $904 · 2024: $540 · 2025: $945.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,306 · Travel and Lodging: $83.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,305.91 |
| Travel and Lodging | $83.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,083.90 | 2021-2023 | Da Vinci Surgical System |
| Axonics, INC. | $550.18 | 2022-2024 | Axonics |
| Procept Biorobotics Corporation | $420.19 | 2022-2025 | Aquabeam System |
| Astellas Pharma US INC | $416.54 | 2021-2025 | Veozah, Myrbetriq, Xtandi |
| Sumitomo Pharma America, INC. | $384.95 | 2023-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $341.62 | 2021-2025 | |
| Myriad Genetic Laboratories, INC. | $211.12 | 2021-2025 | Prolaris |
| Janssen Biotech, INC. | $172.82 | 2022-2025 | Erleada |
| Teleflex LLC | $159.28 | 2021-2023 | Urolift |
| Endo Pharmaceuticals INC. | $135.29 | 2020-2023 | Edex, Xiaflex, Aveed |
| Neotract INC. | $76.68 | 2020 | |
| Medtronic, INC. | $73.43 | 2021-2023 | Interstim |
| Urovant Sciences INC | $64.02 | 2022 | |
| Rochester Medical Corporation | $52.14 | 2021 | |
| Blue Earth Diagnostics | $48.57 | 2021-2023 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $43.20 | 2024-2025 | |
| Boston Scientific Corporation | $42.86 | 2021-2025 | Advantage System |
| Myovant Sciences INC. | $40.23 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $39.38 | 2025 | |
| Antares Pharma, INC. | $35.64 | 2020-2021 | |
| Sun Pharmaceutical Industries INC. | $34.27 | 2024 | |
| 180 Medical, INC. | $29.60 | 2021 | |
| Dendreon Pharmaceuticals LLC | $29.08 | 2025 | Provenge |
| Baxter Healthcare | $28.74 | 2021 | |
| Ethicon US, LLC | $27.68 | 2023 | Certus 140 |
| Ferring Pharmaceuticals INC. | $27.33 | 2025 | Adstiladrin |
| C. R. Bard, INC. & Subsidiaries | $26.59 | 2023 | Bard Urinary Drainage Bag |
| Lsi Solutions INC | $24.89 | 2024 | Jnw Urtrac |
| Coloplast Corp | $24.61 | 2022 | |
| Tolmar, INC. | $23.25 | 2025 | Eligard, Jatenzo |
| Endo USA, INC. | $23.23 | 2024 | Xiaflex, Aveed, Edex |
| Merck Sharp & Dohme LLC | $20.36 | 2025 | Keytruda |
| Allergan, INC. | $18.91 | 2021 | |
| Assertio Therapeutics, INC. | $14.42 | 2020 | |
| Amgen INC. | $11.13 | 2022 | |
| Travere Therapeutics, INC. | $6.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Farrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.